BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Drug Development

  Accera, Inc. Announces Results of Phase II Study in Alzheimer’s Disease at American Academy of Neurology Meeting

  May 2, 2007

   · 

  3 min read
• Deals

  NeurogesX, Inc. Prices Initial Public Offering

  May 2, 2007

   · 

  1 min read
• Business

  Critical Therapeutics, Inc.’ Co-Promotion Partner, Dey, L.P. Launches U.S. Sales and Marketing of ZYFLO(R) for Asthma

  May 2, 2007

   · 

  1 min read
• BioCapital

  ApothéCure Recalls Compounded Injectable Colchicine All Strengths, Sizes and Lots

  May 2, 2007

   · 

  1 min read
• Pharm Country

  OLIGOMERIX Awarded National Institutes of Health (NIH) Grant to Develop Novel Drug Discovery Technology for Alzheimer’s Disease

  May 2, 2007

   · 

  1 min read
• Deals

  Cumberland Pharmaceuticals Files for $115 Million IPO

  May 2, 2007

   · 

  1 min read
• Biotech Bay

  SpinalMotion’s Kineflex(R) Artificial Lumbar Disc Long-Term Data Presented at International Spine Meeting

  May 2, 2007

   · 

  1 min read
• FDA

  FDA Approves Oscient Pharmaceuticals Corporation’s FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia

  May 2, 2007

   · 

  7 min read
• Drug Development

  Nabi Biopharmaceuticals Shares Rise on Positive Results of Phase IIb Trial of NicVAX

  May 2, 2007

   · 

  11 min read
• Deals

  Orexigen Therapeutics, Inc. Completes Initial Public Offering

  May 2, 2007

   · 

  1 min read